Department of Cardiac Electrophysiology and Pacing, Istituto Clinico Sant'Ambrogio, Milan, Italy.
Department of Anesthesia and Intensive Care, Istituto Clinico Sant'Ambrogio, Milan, Italy.
Acta Myol. 2020 Mar 1;39(1):32-35. doi: 10.36185/2532-1900-006. eCollection 2020 Mar.
A significant number of sudden death (SD) is observed in myotonic dystrophy (DM1) despite pacemaker implantation and some consider the ICD to be the preferential device in patients with conduction disease. According to the latest guidelines, prophylactic ICD implantation in patients with neuromuscular disorder should follow the same recommendations of non-ischemic dilated cardiomyopathy, being reasonable when pacing is needed. We here report a case of DM1 patient who underwent ICD implantation even in the absence of conduction disturbances on ECG and ventricular dysfunction/fibrosis at cardiac magnetic resonance. The occurrence of syncope, non-sustained ventricular tachycardias at 24-Holter ECG monitoring and a family history of SD resulted associated with ventricular fibrillation inducibility at electrophysiological study, favouring ICD implantation. On our advice, DM1 patient with this association of SD risk factors should be targeted for ICD implantation.
尽管植入了起搏器,仍有大量的肌强直性营养不良(DM1)患者发生猝死(SD),一些人认为对于传导疾病患者,ICD 是首选设备。根据最新指南,对于神经肌肉疾病患者,预防性 ICD 植入应遵循非缺血性扩张型心肌病的相同建议,在需要起搏时是合理的。我们在此报告一例 DM1 患者,即使在心电图无传导障碍和心脏磁共振显示心室功能/纤维化的情况下,也进行了 ICD 植入。晕厥的发生、24 小时 Holter 心电图监测到非持续性室性心动过速,以及家族性 SD 史,与电生理研究中的心室颤动诱导相关,这有利于 ICD 植入。根据我们的建议,对于具有这种 SD 风险因素的 DM1 患者,应考虑植入 ICD。